Ipsen: Cabometyx approved by the FDA two months ahead of schedule
BUY-Top Picks, Fair Value EUR60 (+14%)
EDF: The curtain goes up
BUY, Fair Value EUR13,5 (+10%)
Amoéba: A development plan on track
CORPORATE
Worldline: The cheapest stock in our Payment coverage
BUY-Top Picks, Fair Value EUR29 (+34%)
Grandvision: Sounds fundamentals but in the optical industry acquisitions often cause dilution
BUY, Fair Value EUR29 vs. EUR29,5 (+17%)
Axway Software: The remedial test
NEUTRAL, Fair Value EUR24 (+21%)